News

Vijaya Diagnostic Centre Limited will hold a board meeting on November 3, 2026, to consider and approve the standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing with the National Stock Exchange of India Limited and BSE Limited. The trading window for the company`s securities was closed for designated persons and their immediate relatives from October 1, 2026, and will remain closed until November 5, 2026.

Vijaya Diagnostic Centre Limited certified to the National Stock Exchange of India Limited and BSE Limited that details of dematerialized/rematerialized securities for the quarter ended September 30, 2026, have been furnished, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, with KFin Technologies Limited acting as registrar to an issue and share transfer agent.

Vijaya Diagnostic Centre Limited informed the National Stock Exchange of India Limited and BSE Limited that the trading window for dealing in securities of the company will be closed from Thursday, October 01, 2026, until 48 hours after the announcement of the unaudited financial results for the quarter ending September 30, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Vijaya Diagnostic Centre Limited announced the appointment of Dr. Venkata Naresh Yallapragada as Chief Information Officer (CIO), effective September 2, 2026.

Vijaya Diagnostic Centre Limited will hold its 24th Annual General Meeting on September 24, 2026, to seek shareholder approval for a final dividend of Rs 2 per equity share, or 200%, for fiscal year 2025-26, with Wednesday, September 16, 2026, set as the record date for determining dividend eligibility and voting rights, and KFin Technologies Limited (KFin) serving as the e-voting platform provider with a cut-off date of Wednesday, September 16, 2026.